ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE

ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE was reported 4719 times

ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AUTISM SPECTRUM DISORDER 51 0.0093
1 BRONCHITIS ACUTE 3 0.0075
2 ACUTE HEPATIC FAILURE 86 0.0063
3 HOARSENESS 3 0.0062
4 PULMONARY ARTERY STENOSIS CONGENITAL 4 0.0055
5 HAEMORRHAGIC STROKE 34 0.0043
6 CERVICAL RADICULOPATHY 3 0.0042
7 ATROPHIC VULVOVAGINITIS 3 0.0041
8 MASTOIDITIS 4 0.0041
9 POLYTRAUMATISM 5 0.0037
10 CARTILAGE ATROPHY 3 0.0037
11 FEAR OF FALLING 3 0.0037
12 LUMBAR RADICULOPATHY 4 0.0035
13 PULMONARY VALVE INCOMPETENCE 5 0.0034
14 COSTOCHONDRITIS 5 0.0031
15 DRUG ADMINISTRATION ERROR 89 0.0029
16 INTRAVENTRICULAR HAEMORRHAGE 7 0.0028
17 VENTRICULAR HYPERTROPHY 7 0.0028
18 HAEMORRHAGIC ANAEMIA 12 0.0027
19 ANEURYSM 13 0.0026
20 DILATATION ATRIAL 3 0.0026
21 PRE-EXISTING CONDITION IMPROVED 16 0.0026
22 PROTHROMBIN TIME PROLONGED 15 0.0025
23 LACUNAR INFARCTION 6 0.0025
24 INTRACRANIAL ANEURYSM 10 0.0025
25 PRODUCT ADMINISTRATION ERROR 49 0.0024
26 HEPATIC NECROSIS 9 0.0024
27 HEPATORENAL SYNDROME 4 0.0024
28 FACIAL PALSY 5 0.0023
29 ESSENTIAL HYPERTENSION 4 0.0022
30 CHRONIC FATIGUE SYNDROME 3 0.0022
31 BRAIN HERNIATION 6 0.0020
32 GASTROINTESTINAL WALL THICKENING 3 0.0020
33 MUSCLE CONTRACTURE 4 0.0020
34 SELF INJURIOUS BEHAVIOUR 6 0.0020
35 DILATATION VENTRICULAR 4 0.0019
36 NEUROGENIC BLADDER 4 0.0019
37 AORTIC VALVE INCOMPETENCE 8 0.0019
38 SOMNAMBULISM 12 0.0018
39 COLONOSCOPY 4 0.0018
40 RED BLOOD CELL COUNT INCREASED 5 0.0018
41 INTENTIONAL OVERDOSE 115 0.0018
42 SKIN HYPERTROPHY 5 0.0018
43 ATELECTASIS 17 0.0018
44 TACHYPHRENIA 6 0.0017
45 DRUG MONITORING PROCEDURE NOT PERFORMED 3 0.0017
46 BRAIN OEDEMA 21 0.0017
47 PRODUCT ADMINISTRATION INTERRUPTED 13 0.0017
48 CHEST X-RAY ABNORMAL 5 0.0016
49 ULCER HAEMORRHAGE 11 0.0016
50 LOWER GASTROINTESTINAL HAEMORRHAGE 12 0.0016
51 TALIPES 5 0.0016
52 BLADDER SPASM 3 0.0016
53 MATERNAL EXPOSURE TIMING UNSPECIFIED 6 0.0016
54 SNORING 6 0.0016
55 DRUG TITRATION ERROR 4 0.0015
56 HEPATIC ENCEPHALOPATHY 14 0.0015
57 ALCOHOL ABUSE 4 0.0015
58 PLANTAR FASCIITIS 5 0.0015
59 SELF-INJURIOUS IDEATION 6 0.0014
60 ATTENTION DEFICIT HYPERACTIVITY DISORDER 6 0.0014
61 HANGOVER 5 0.0014
62 EYE CONTUSION 3 0.0014
63 HEMIPARESIS 24 0.0014
64 MULTIPLE DRUG OVERDOSE 7 0.0014
65 OXYGEN SATURATION ABNORMAL 4 0.0014
66 LUNG CANCER METASTATIC 4 0.0014
67 VITAMIN B12 DECREASED 4 0.0014
68 DYSPHEMIA 6 0.0014
69 CHOLECYSTITIS CHRONIC 9 0.0013
70 COAGULOPATHY 22 0.0013
71 HAEMATOCRIT INCREASED 3 0.0013
72 BRAIN OPERATION 3 0.0013
73 EAR DISORDER 6 0.0013
74 DYSCHEZIA 4 0.0013
75 COMPRESSION FRACTURE 7 0.0013
76 RECTAL CANCER 4 0.0013
77 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
78 CONCUSSION 10 0.0013
79 SENSATION OF HEAVINESS 5 0.0013
80 FOREIGN BODY IN THROAT 4 0.0013
81 NON-CARDIAC CHEST PAIN 4 0.0013
82 SUICIDE ATTEMPT 76 0.0013
83 HAEMOGLOBIN ABNORMAL 8 0.0012
84 LOOSE TOOTH 4 0.0012
85 CARDIAC FLUTTER 8 0.0012
86 HOMICIDAL IDEATION 5 0.0012
87 BREATH ODOUR 3 0.0012
88 CARPAL TUNNEL SYNDROME 17 0.0012
89 LIGAMENT SPRAIN 12 0.0012
90 PEPTIC ULCER 4 0.0012
91 SEASONAL ALLERGY 17 0.0012
92 HYPOVOLAEMIA 7 0.0012
93 EYELID IRRITATION 3 0.0012
94 CEREBRAL HAEMATOMA 4 0.0012
95 SUBARACHNOID HAEMORRHAGE 12 0.0012
96 CARBOHYDRATE ANTIGEN 125 INCREASED 4 0.0012
97 BLOOD CREATININE ABNORMAL 4 0.0012
98 HERNIA REPAIR 3 0.0012
99 AORTIC STENOSIS 4 0.0011
100 CAROTID ARTERY STENOSIS 4 0.0011
101 DIVERTICULUM INTESTINAL 5 0.0011
102 DRUG SCREEN POSITIVE 9 0.0011
103 TRICUSPID VALVE INCOMPETENCE 9 0.0011
104 BLOOD POTASSIUM ABNORMAL 3 0.0011
105 ALCOHOL POISONING 3 0.0011
106 BLOOD PRESSURE SYSTOLIC DECREASED 5 0.0011
107 BLOOD IRON DECREASED 13 0.0011
108 BLOOD PHOSPHORUS DECREASED 4 0.0011
109 INCREASED TENDENCY TO BRUISE 10 0.0011
110 INCOHERENT 7 0.0011
111 FREEZING PHENOMENON 4 0.0011
112 INTRACRANIAL PRESSURE INCREASED 6 0.0011
113 INITIAL INSOMNIA 11 0.0011
114 HEPATIC FAILURE 32 0.0011
115 MITRAL VALVE INCOMPETENCE 12 0.0011
116 GINGIVAL DISORDER 4 0.0010
117 RENAL FAILURE CHRONIC 8 0.0010
118 OESOPHAGEAL ULCER 4 0.0010
119 EYELID MARGIN CRUSTING 3 0.0010
120 HYPERCHOLESTEROLAEMIA 10 0.0010
121 VITAMIN D DEFICIENCY 10 0.0010
122 ROTATOR CUFF SYNDROME 13 0.0010
123 HYPERVOLAEMIA 5 0.0010
124 SKIN LACERATION 11 0.0010
125 PATENT DUCTUS ARTERIOSUS 4 0.0010
126 SENSORY LOSS 8 0.0010
127 TRANSAMINASES INCREASED 22 0.0010
128 ACUTE RESPIRATORY FAILURE 19 0.0010
129 ABNORMAL DREAMS 27 0.0010
130 SELF-MEDICATION 4 0.0010
131 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 6 0.0010
132 ATRIAL SEPTAL DEFECT 8 0.0010
133 HALLUCINATIONS, MIXED 4 0.0010
134 CANDIDA INFECTION 16 0.0009
135 CEREBROVASCULAR ACCIDENT 160 0.0009
136 FEELING DRUNK 7 0.0009
137 SCREAMING 6 0.0009
138 ESCHERICHIA URINARY TRACT INFECTION 4 0.0009
139 INCORRECT DRUG ADMINISTRATION RATE 4 0.0009
140 LIVER INJURY 23 0.0009
141 MENTAL STATUS CHANGES 26 0.0009
142 LEFT VENTRICULAR HYPERTROPHY 4 0.0009
143 INSOMNIA 247 0.0009
144 BLOOD MAGNESIUM DECREASED 8 0.0009
145 MONOPLEGIA 4 0.0009
146 HYDROCEPHALUS 5 0.0009
147 JAW DISORDER 5 0.0009
148 ONYCHOMYCOSIS 4 0.0009
149 ASTHENOPIA 5 0.0009
150 LIGAMENT RUPTURE 4 0.0009
151 MUSCULOSKELETAL CHEST PAIN 14 0.0009
152 UPPER LIMB FRACTURE 18 0.0009
153 RHINITIS ALLERGIC 4 0.0009
154 MULTIPLE ALLERGIES 7 0.0009
155 CLOSTRIDIAL INFECTION 3 0.0009
156 PERONEAL NERVE PALSY 5 0.0009
157 HAEMOGLOBIN INCREASED 4 0.0009
158 EAR DISCOMFORT 9 0.0009
159 HYPERSOMNIA 25 0.0009
160 ONYCHOCLASIS 6 0.0009
161 VISUAL DISTURBANCE 5 0.0009
162 CERVICAL VERTEBRAL FRACTURE 3 0.0009
163 SKIN ATROPHY 5 0.0009
164 BLOOD PRESSURE DIASTOLIC INCREASED 4 0.0009
165 PERFORMANCE STATUS DECREASED 4 0.0009
166 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
167 SKIN ABRASION 4 0.0008
168 FULL BLOOD COUNT DECREASED 17 0.0008
169 HAEMORRHAGIC DIATHESIS 3 0.0008
170 PRE-ECLAMPSIA 4 0.0008
171 DECREASED ACTIVITY 9 0.0008
172 PANIC REACTION 6 0.0008
173 VULVOVAGINAL PAIN 4 0.0008
174 NOCTURIA 10 0.0008
175 INTERVERTEBRAL DISC PROTRUSION 18 0.0008
176 MUSCLE SPASTICITY 10 0.0008
177 HOSPICE CARE 8 0.0008
178 BLOOD CALCIUM DECREASED 9 0.0008
179 NAIL DISORDER 7 0.0008
180 BRAIN INJURY 8 0.0008
181 FACE INJURY 3 0.0008
182 ACIDOSIS 6 0.0008
183 COMMUNICATION DISORDER 3 0.0008
184 AMNESIA 51 0.0008
185 RIB FRACTURE 16 0.0008
186 GASTROENTERITIS VIRAL 14 0.0008
187 CONGENITAL ANOMALY 6 0.0008
188 FAECES HARD 3 0.0008
189 FAILURE TO THRIVE 4 0.0008
190 VENTRICULAR EXTRASYSTOLES 8 0.0008
191 RESTLESS LEGS SYNDROME 14 0.0008
192 EPIGASTRIC DISCOMFORT 3 0.0008
193 TENDON DISORDER 5 0.0008
194 EXOSTOSIS 7 0.0008
195 POLYP 5 0.0008
196 FURUNCLE 6 0.0008
197 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
198 DYSSTASIA 22 0.0008
199 NIGHTMARE 26 0.0008
200 GASTROINTESTINAL MOTILITY DISORDER 4 0.0007
201 POST-TRAUMATIC STRESS DISORDER 5 0.0007
202 NIGHT SWEATS 24 0.0007
203 LACERATION 7 0.0007
204 CARDIOMYOPATHY 11 0.0007
205 DYSPNOEA EXERTIONAL 28 0.0007
206 GALLBLADDER OPERATION 3 0.0007
207 SINUS CONGESTION 10 0.0007
208 SPINAL DISORDER 7 0.0007
209 FOOT FRACTURE 14 0.0007
210 BACK DISORDER 12 0.0007
211 SUBSTANCE ABUSE 6 0.0007
212 THERAPEUTIC RESPONSE UNEXPECTED 33 0.0007
213 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
214 HICCUPS 6 0.0007
215 EYE MOVEMENT DISORDER 5 0.0007
216 NEPHROTIC SYNDROME 5 0.0007
217 ECCHYMOSIS 5 0.0007
218 HEAD INJURY 23 0.0007
219 CHOKING SENSATION 4 0.0007
220 JOINT EFFUSION 5 0.0007
221 SLEEP DISORDER 51 0.0007
222 HEMIPLEGIA 6 0.0007
223 EAR PAIN 14 0.0007
224 CONGESTIVE CARDIOMYOPATHY 3 0.0007
225 LEUKOCYTOSIS 13 0.0007
226 HIP ARTHROPLASTY 11 0.0007
227 HUNGER 10 0.0007
228 HAEMORRHOIDS 14 0.0007
229 HEART RATE ABNORMAL 4 0.0007
230 RENAL TUBULAR NECROSIS 7 0.0007
231 RIGHT VENTRICULAR FAILURE 5 0.0007
232 BONE DISORDER 13 0.0007
233 LETHARGY 41 0.0007
234 DELUSION 11 0.0007
235 BUNDLE BRANCH BLOCK LEFT 3 0.0007
236 RENAL FAILURE ACUTE 30 0.0007
237 DIVERTICULUM 5 0.0007
238 FOETAL EXPOSURE DURING PREGNANCY 57 0.0007
239 VENTRICULAR SEPTAL DEFECT 4 0.0007
240 BLOOD POTASSIUM DECREASED 21 0.0007
241 ABNORMAL SENSATION IN EYE 3 0.0007
242 THINKING ABNORMAL 13 0.0007
243 GASTROOESOPHAGEAL REFLUX DISEASE 56 0.0007
244 POLLAKIURIA 29 0.0007
245 CARDIAC MURMUR 6 0.0007
246 EXPIRED PRODUCT ADMINISTERED 23 0.0007
247 VISUAL FIELD DEFECT 5 0.0007
248 HYPOTHERMIA 7 0.0007
249 CONSTIPATION 150 0.0007
250 ACCIDENTAL OVERDOSE 25 0.0007
251 SPINAL OSTEOARTHRITIS 6 0.0007
252 SLEEP APNOEA SYNDROME 13 0.0007
253 LUNG INFILTRATION 6 0.0007
254 DRY MOUTH 55 0.0007
255 RECTAL HAEMORRHAGE 29 0.0007
256 ATAXIA 8 0.0007
257 SINUS HEADACHE 4 0.0007
258 VERTIGO 41 0.0007
259 GALLBLADDER DISORDER 12 0.0007
260 CHOLELITHIASIS 22 0.0007
261 PETECHIAE 7 0.0007
262 ODYNOPHAGIA 4 0.0007
263 MACULAR DEGENERATION 8 0.0007
264 INJURY 47 0.0007
265 CONVULSION 38 0.0007
266 HALLUCINATION, VISUAL 14 0.0007
267 TOOTHACHE 12 0.0007
268 CHRONIC KIDNEY DISEASE 50 0.0007
269 EATING DISORDER 14 0.0007
270 SINUS DISORDER 13 0.0007
271 CORONARY ARTERY OCCLUSION 9 0.0007
272 UPPER GASTROINTESTINAL HAEMORRHAGE 11 0.0007
273 PROSTATIC SPECIFIC ANTIGEN INCREASED 9 0.0007
274 MUSCLE TWITCHING 15 0.0007
275 CARDIOMEGALY 8 0.0006
276 BLOOD CHOLESTEROL ABNORMAL 3 0.0006
277 SPINAL FRACTURE 13 0.0006
278 ARTHRITIS 51 0.0006
279 PIGMENTATION DISORDER 4 0.0006
280 ORAL DISCOMFORT 9 0.0006
281 ARTHRITIS INFECTIVE 3 0.0006
282 ANKLE FRACTURE 10 0.0006
283 HEPATIC STEATOSIS 12 0.0006
284 FLANK PAIN 6 0.0006
285 BLINDNESS UNILATERAL 9 0.0006
286 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
287 OSTEOARTHRITIS 27 0.0006
288 MUSCLE ATROPHY 8 0.0006
289 PRODUCT PACKAGING ISSUE 6 0.0006
290 PANIC ATTACK 23 0.0006
291 RESPIRATORY TRACT CONGESTION 10 0.0006
292 GINGIVAL PAIN 5 0.0006
293 LIMB INJURY 17 0.0006
294 WHITE BLOOD CELL COUNT INCREASED 24 0.0006
295 ORAL PAIN 14 0.0006
296 ANGER 21 0.0006
297 FRUSTRATION TOLERANCE DECREASED 5 0.0006
298 NEURALGIA 15 0.0006
299 HEPATITIS ACUTE 4 0.0006
300 POST PROCEDURAL INFECTION 5 0.0006
301 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
302 PLATELET COUNT INCREASED 8 0.0006
303 DECUBITUS ULCER 5 0.0006
304 INCORRECT DOSAGE ADMINISTERED 3 0.0006
305 VITREOUS FLOATERS 6 0.0006
306 BREATH SOUNDS ABNORMAL 3 0.0006
307 SPINAL COMPRESSION FRACTURE 5 0.0006
308 PULMONARY MASS 9 0.0006
309 BLOOD PRESSURE ABNORMAL 12 0.0006
310 END STAGE RENAL DISEASE 11 0.0006
311 AGEUSIA 15 0.0006
312 HYPERAMMONAEMIA 3 0.0006
313 DYSPEPSIA 59 0.0006
314 GASTROINTESTINAL HAEMORRHAGE 50 0.0006
315 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
316 CORONARY ARTERY STENOSIS 3 0.0006
317 OSTEOPENIA 9 0.0006
318 PRODUCT LABEL ISSUE 4 0.0006
319 MIDDLE INSOMNIA 11 0.0006
320 IMPAIRED GASTRIC EMPTYING 8 0.0006
321 HEPATIC CIRRHOSIS 11 0.0006
322 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 3 0.0006
323 VITAMIN D DECREASED 5 0.0006
324 DYSARTHRIA 22 0.0006
325 ASPARTATE AMINOTRANSFERASE INCREASED 31 0.0006
326 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
327 MUSCLE STRAIN 5 0.0006
328 BASAL CELL CARCINOMA 9 0.0006
329 PRESYNCOPE 14 0.0006
330 INCREASED APPETITE 11 0.0006
331 FORMICATION 4 0.0006
332 FEELING COLD 16 0.0006
333 BRAIN FOG 9 0.0006
334 WEIGHT FLUCTUATION 6 0.0006
335 URINE OUTPUT DECREASED 5 0.0006
336 JOINT STIFFNESS 15 0.0006
337 DYSURIA 21 0.0006
338 HYPOXIA 20 0.0006
339 MUSCLE SPASMS 104 0.0006
340 ASTHENIA 213 0.0006
341 OVERDOSE 122 0.0006
342 CYSTITIS 18 0.0006
343 OBESITY 9 0.0006
344 HEAD DISCOMFORT 10 0.0006
345 DYSPHONIA 33 0.0006
346 WHITE BLOOD CELL COUNT DECREASED 61 0.0006
347 BLOOD PRESSURE INCREASED 86 0.0006
348 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 40 0.0006
349 NASAL CONGESTION 33 0.0006
350 INTERNATIONAL NORMALISED RATIO INCREASED 16 0.0006
351 PRODUCT SUPPLY ISSUE 4 0.0006
352 SECRETION DISCHARGE 7 0.0006
353 FATIGUE 435 0.0006
354 POOR QUALITY SLEEP 12 0.0006
355 HOT FLUSH 42 0.0006
356 BRUXISM 3 0.0006
357 GINGIVITIS 3 0.0006
358 FALL 185 0.0006
359 BALANCE DISORDER 48 0.0006
360 FEELING HOT 34 0.0006
361 HIP SURGERY 3 0.0006
362 INCORRECT PRODUCT ADMINISTRATION DURATION 12 0.0006
363 HYPOKINESIA 8 0.0006
364 LIP DRY 5 0.0005
365 DEHYDRATION 73 0.0005
366 UTERINE LEIOMYOMA 4 0.0005
367 BONE PAIN 32 0.0005
368 MYDRIASIS 7 0.0005
369 TOOTH FRACTURE 6 0.0005
370 TASTE DISORDER 11 0.0005
371 LABORATORY TEST ABNORMAL 16 0.0005
372 UROSEPSIS 5 0.0005
373 DYSKINESIA 22 0.0005
374 NERVE INJURY 6 0.0005
375 HEPATOTOXICITY 12 0.0005
376 DECREASED APPETITE 125 0.0005
377 BLOOD UREA INCREASED 9 0.0005
378 RENAL DISORDER 25 0.0005
379 HAEMOGLOBIN DECREASED 55 0.0005
380 COGNITIVE DISORDER 25 0.0005
381 HEART RATE INCREASED 53 0.0005
382 DEFORMITY 5 0.0005
383 FIBROMYALGIA 13 0.0005
384 OXYGEN SATURATION DECREASED 30 0.0005
385 PHOTOPHOBIA 10 0.0005
386 DIZZINESS 265 0.0005
387 SQUAMOUS CELL CARCINOMA 5 0.0005
388 TOOTH INFECTION 7 0.0005
389 HALLUCINATION 40 0.0005
390 HYPOAESTHESIA ORAL 8 0.0005
391 CEREBRAL HAEMORRHAGE 19 0.0005
392 PAROSMIA 4 0.0005
393 DISORIENTATION 21 0.0005
394 CHOLECYSTITIS ACUTE 3 0.0005
395 MUSCULAR WEAKNESS 60 0.0005
396 SPUTUM DISCOLOURED 5 0.0005
397 NEUROPATHY PERIPHERAL 50 0.0005
398 INTENTIONAL PRODUCT MISUSE 46 0.0005
399 DYSGEUSIA 39 0.0005
400 FEELING JITTERY 10 0.0005
401 NEPHROLITHIASIS 24 0.0005
402 TINNITUS 24 0.0005
403 BOWEL MOVEMENT IRREGULARITY 4 0.0005
404 SKIN DISCOLOURATION 24 0.0005
405 DEVICE PHYSICAL PROPERTY ISSUE 4 0.0005
406 LIPASE INCREASED 4 0.0005
407 QUALITY OF LIFE DECREASED 7 0.0005
408 HERPES VIRUS INFECTION 3 0.0005
409 BLOOD BILIRUBIN INCREASED 14 0.0005
410 NERVOUSNESS 27 0.0005
411 SOMNOLENCE 104 0.0005
412 POST PROCEDURAL HAEMORRHAGE 6 0.0005
413 IRRITABLE BOWEL SYNDROME 11 0.0005
414 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
415 INFLAMMATORY BOWEL DISEASE 5 0.0005
416 GASTROINTESTINAL INFLAMMATION 4 0.0005
417 COELIAC DISEASE 5 0.0005
418 ENERGY INCREASED 3 0.0005
419 COVID-19 PNEUMONIA 6 0.0005
420 BLOOD ALBUMIN DECREASED 4 0.0005
421 URINARY TRACT INFECTION 86 0.0005
422 CARDIAC PACEMAKER INSERTION 3 0.0005
423 COORDINATION ABNORMAL 7 0.0005
424 SCIATICA 8 0.0005
425 ATRIAL FLUTTER 4 0.0005
426 MASS 7 0.0005
427 WRIST FRACTURE 6 0.0005
428 OVARIAN CYST 5 0.0005
429 PERIPHERAL SWELLING 77 0.0005
430 BLOOD PRESSURE INADEQUATELY CONTROLLED 3 0.0005
431 CONTUSION 48 0.0005
432 WEIGHT DECREASED 139 0.0005
433 MUSCULOSKELETAL PAIN 26 0.0005
434 INTENTIONAL SELF-INJURY 10 0.0005
435 RHINORRHOEA 32 0.0005
436 MENTAL IMPAIRMENT 12 0.0005
437 TOOTH DISORDER 11 0.0005
438 PRODUCT DOSE OMISSION IN ERROR 14 0.0005
439 FLATULENCE 28 0.0005
440 BLOOD CHOLESTEROL INCREASED 23 0.0005
441 SINUS TACHYCARDIA 7 0.0005
442 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 27 0.0005
443 RESTLESSNESS 18 0.0005
444 SLUGGISHNESS 5 0.0005
445 AGITATION 36 0.0005
446 CYTOPENIA 6 0.0005
447 RED BLOOD CELL COUNT DECREASED 14 0.0005
448 ALANINE AMINOTRANSFERASE INCREASED 30 0.0005
449 DRUG ABUSER 3 0.0005
450 EUPHORIC MOOD 5 0.0005
451 CATARACT 29 0.0005
452 HYPERAESTHESIA 4 0.0005
453 HELICOBACTER INFECTION 5 0.0005
454 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
455 GAIT DISTURBANCE 93 0.0005
456 ABDOMINAL PAIN UPPER 100 0.0005
457 HAIR DISORDER 4 0.0005
458 LIMB DISCOMFORT 15 0.0005
459 TEMPERATURE INTOLERANCE 5 0.0005
460 HEPATIC ENZYME INCREASED 33 0.0005
461 LOSS OF CONSCIOUSNESS 62 0.0005
462 COMA 23 0.0005
463 PSYCHOMOTOR HYPERACTIVITY 8 0.0005
464 PULMONARY HYPERTENSION 10 0.0005
465 RASH PRURITIC 26 0.0005
466 SPEECH DISORDER 25 0.0005
467 ACUTE KIDNEY INJURY 73 0.0005
468 PLEURAL EFFUSION 29 0.0005
469 BLEPHAROSPASM 3 0.0005
470 GASTRIC ULCER 9 0.0005
471 FULL BLOOD COUNT ABNORMAL 5 0.0005
472 RENAL PAIN 5 0.0005
473 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
474 HYPOPHAGIA 12 0.0005
475 PULMONARY FIBROSIS 9 0.0005
476 METABOLIC ACIDOSIS 15 0.0005
477 ENTERITIS 3 0.0005
478 EPISTAXIS 35 0.0005
479 PRODUCT CONTAINER ISSUE 4 0.0005
480 ERUCTATION 9 0.0005
481 MUSCULOSKELETAL DISCOMFORT 8 0.0005
482 SKIN ULCER 12 0.0005
483 APHASIA 14 0.0005
484 PSYCHOLOGICAL TRAUMA 4 0.0005
485 PRURITUS GENERALISED 10 0.0005
486 CORONARY ARTERY DISEASE 14 0.0005
487 STOMATITIS 28 0.0005
488 DEEP VEIN THROMBOSIS 30 0.0005
489 ANGINA UNSTABLE 3 0.0005
490 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
491 BRADYPHRENIA 3 0.0005
492 KIDNEY INFECTION 9 0.0005
493 BLOOD PRESSURE FLUCTUATION 11 0.0005
494 IMPAIRED HEALING 15 0.0005
495 ASPIRATION 5 0.0005
496 EYE DISORDER 15 0.0005
497 INTENTIONAL DOSE OMISSION 13 0.0005
498 PULMONARY CONGESTION 6 0.0005
499 PHARYNGEAL OEDEMA 7 0.0005
500 UPPER RESPIRATORY TRACT INFECTION 21 0.0005
501 GASTROINTESTINAL PAIN 5 0.0005
502 ABNORMAL BEHAVIOUR 18 0.0005
503 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
504 APPETITE DISORDER 3 0.0005
505 PULMONARY EMBOLISM 43 0.0005
506 PURPURA 4 0.0005
507 DENTAL CARIES 5 0.0005
508 DIARRHOEA 291 0.0005
509 LUNG INFECTION 7 0.0005
510 EJECTION FRACTION DECREASED 7 0.0004
511 CEREBRAL INFARCTION 11 0.0004
512 URINARY RETENTION 15 0.0004
513 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
514 HYPOAESTHESIA 67 0.0004
515 JOINT RANGE OF MOTION DECREASED 6 0.0004
516 NECK PAIN 25 0.0004
517 INCORRECT DOSE ADMINISTERED 102 0.0004
518 GASTROINTESTINAL INFECTION 4 0.0004
519 NAUSEA 353 0.0004
520 CYANOSIS 7 0.0004
521 FISTULA 5 0.0004
522 OROPHARYNGEAL PAIN 41 0.0004
523 FLUSHING 45 0.0004
524 HYPOACUSIS 19 0.0004
525 BODY TEMPERATURE INCREASED 9 0.0004
526 PLATELET COUNT DECREASED 47 0.0004
527 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 23 0.0004
528 DRUG EFFECT INCOMPLETE 16 0.0004
529 IMPAIRED DRIVING ABILITY 5 0.0004
530 BLOOD TESTOSTERONE DECREASED 3 0.0004
531 FEELING ABNORMAL 105 0.0004
532 MICTURITION URGENCY 5 0.0004
533 SENSORY DISTURBANCE 7 0.0004
534 ABDOMINAL DISCOMFORT 73 0.0004
535 DEPRESSION 99 0.0004
536 SHOCK 10 0.0004
537 DROOLING 3 0.0004
538 NERVE COMPRESSION 4 0.0004
539 HYPOKALAEMIA 20 0.0004
540 DIVERTICULITIS 12 0.0004
541 MUSCLE TIGHTNESS 7 0.0004
542 ARTHROPATHY 24 0.0004
543 ATRIAL FIBRILLATION 42 0.0004
544 INTENTIONAL DRUG MISUSE 9 0.0004
545 SYNCOPE 43 0.0004
546 MEMORY IMPAIRMENT 59 0.0004
547 RENAL FAILURE 57 0.0004
548 NEPHROPATHY 4 0.0004
549 SPLENOMEGALY 5 0.0004
550 OEDEMA PERIPHERAL 52 0.0004
551 EYE PAIN 24 0.0004
552 RESPIRATORY FAILURE 31 0.0004
553 HYPERTENSION 90 0.0004
554 HAEMATOMA 11 0.0004
555 DIPLOPIA 11 0.0004
556 DIALYSIS 6 0.0004
557 JOINT SWELLING 51 0.0004
558 BACK PAIN 98 0.0004
559 ANXIETY 120 0.0004
560 BACTERAEMIA 5 0.0004
561 FEAR OF INJECTION 3 0.0004
562 CHOLECYSTITIS 5 0.0004
563 ANAEMIA 80 0.0004
564 PRODUCTIVE COUGH 20 0.0004
565 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
566 HYPERLIPIDAEMIA 5 0.0004
567 VOMITING 196 0.0004
568 HAEMATOCHEZIA 23 0.0004
569 PARAESTHESIA ORAL 6 0.0004
570 VISION BLURRED 57 0.0004
571 FAECES DISCOLOURED 9 0.0004
572 TRANSIENT ISCHAEMIC ATTACK 14 0.0004
573 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
574 EAR INFECTION 11 0.0004
575 PARAESTHESIA 65 0.0004
576 FLUID RETENTION 21 0.0004
577 LIVER FUNCTION TEST ABNORMAL 12 0.0004
578 FAECES SOFT 3 0.0004
579 DIZZINESS POSTURAL 4 0.0004
580 BURSITIS 5 0.0004
581 PARKINSONISM 4 0.0004
582 SINUSITIS 42 0.0004
583 TREMOR 68 0.0004
584 HEADACHE 256 0.0004
585 BODY TEMPERATURE DECREASED 4 0.0004
586 SMALL INTESTINAL OBSTRUCTION 5 0.0004
587 HYPOPHOSPHATAEMIA 3 0.0004
588 ARTHROPOD BITE 3 0.0004
589 ABASIA 10 0.0004
590 RENAL INJURY 12 0.0004
591 GLOSSODYNIA 9 0.0004
592 HAIR COLOUR CHANGES 5 0.0004
593 SNEEZING 9 0.0004
594 HYDRONEPHROSIS 3 0.0004
595 PAIN IN EXTREMITY 118 0.0004
596 INJECTION SITE DISCOLOURATION 5 0.0004
597 CARDIAC FAILURE CONGESTIVE 32 0.0004
598 BLOOD COUNT ABNORMAL 6 0.0004
599 LYMPHADENOPATHY 14 0.0004
600 PRODUCT USE IN UNAPPROVED INDICATION 98 0.0004
601 VAGINAL DISCHARGE 4 0.0004
602 HAEMOPTYSIS 11 0.0004
603 HAEMODYNAMIC INSTABILITY 3 0.0004
604 DRUG DOSE OMISSION 65 0.0004
605 CHILLS 46 0.0004
606 COUGH 110 0.0004
607 INCORRECT DRUG ADMINISTRATION DURATION 11 0.0004
608 GOUT 7 0.0004
609 CONFUSIONAL STATE 63 0.0004
610 OSTEOPOROSIS 16 0.0004
611 PRODUCT USE ISSUE 73 0.0004
612 ATRIOVENTRICULAR BLOCK 3 0.0004
613 INFUSION SITE PAIN 5 0.0004
614 ARTHRALGIA 161 0.0004
615 HIATUS HERNIA 5 0.0004
616 RASH GENERALISED 10 0.0004
617 CRYING 14 0.0004
618 NASOPHARYNGITIS 71 0.0004
619 TENDERNESS 4 0.0004
620 ABDOMINAL DISTENSION 40 0.0004
621 SEDATION 10 0.0004
622 TRANSFUSION 4 0.0004
623 DRY EYE 19 0.0004
624 BEDRIDDEN 5 0.0004
625 IMMUNE SYSTEM DISORDER 5 0.0004
626 DYSPHAGIA 36 0.0004
627 VISUAL IMPAIRMENT 47 0.0004
628 HYPOTENSION 76 0.0004
629 INCONTINENCE 4 0.0004
630 INFLUENZA LIKE ILLNESS 31 0.0004
631 PAIN 231 0.0004
632 RETCHING 8 0.0004
633 BODY HEIGHT DECREASED 4 0.0004
634 HEREDITARY ANGIOEDEMA 4 0.0004
635 LIVER FUNCTION TEST INCREASED 8 0.0004
636 LOCALISED INFECTION 9 0.0004
637 FEAR 10 0.0004
638 SKIN CANCER 8 0.0004
639 BLOOD SODIUM DECREASED 7 0.0004
640 BIPOLAR DISORDER 4 0.0004
641 BACK INJURY 4 0.0004
642 TACHYPNOEA 5 0.0004
643 TOXICITY TO VARIOUS AGENTS 62 0.0004
644 ASPHYXIA 3 0.0004
645 CHEST PAIN 68 0.0004
646 MIGRAINE 35 0.0004
647 OESOPHAGITIS 4 0.0004
648 DYSPNOEA 207 0.0004
649 SKIN LESION 10 0.0004
650 POST PROCEDURAL COMPLICATION 7 0.0004
651 PERIPHERAL COLDNESS 5 0.0004
652 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
653 PHOTOSENSITIVITY REACTION 6 0.0004
654 WEIGHT INCREASED 81 0.0004
655 PROCEDURAL PAIN 10 0.0004
656 PNEUMONIA ASPIRATION 9 0.0004
657 FUNGAL INFECTION 12 0.0004
658 SURGERY 21 0.0004
659 MALNUTRITION 4 0.0004
660 PULMONARY OEDEMA 16 0.0004
661 WITHDRAWAL SYNDROME 15 0.0004
662 RASH PAPULAR 8 0.0004
663 DRUG USE DISORDER 3 0.0004
664 HEART RATE IRREGULAR 8 0.0004
665 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
666 SWELLING FACE 23 0.0004
667 HAEMATOCRIT DECREASED 7 0.0004
668 SWOLLEN TONGUE 11 0.0004
669 MYOCARDIAL ISCHAEMIA 4 0.0004
670 SCAB 4 0.0004
671 THERAPY CESSATION 18 0.0004
672 INTERNAL HAEMORRHAGE 4 0.0003
673 EYE SWELLING 13 0.0003
674 PARALYSIS 5 0.0003
675 IRRITABILITY 21 0.0003
676 PHARMACEUTICAL PRODUCT COMPLAINT 9 0.0003
677 ANOSMIA 5 0.0003
678 FEEDING DISORDER 7 0.0003
679 DEAFNESS 9 0.0003
680 FLUID OVERLOAD 5 0.0003
681 COLITIS 13 0.0003
682 ANHEDONIA 9 0.0003
683 INTENTIONAL PRODUCT USE ISSUE 30 0.0003
684 BURNING SENSATION 24 0.0003
685 HIP FRACTURE 11 0.0003
686 GROIN PAIN 3 0.0003
687 GRIP STRENGTH DECREASED 3 0.0003
688 INFLUENZA 38 0.0003
689 IMMUNOSUPPRESSION 3 0.0003
690 BLISTER 19 0.0003
691 LIVER DISORDER 15 0.0003
692 SKIN HAEMORRHAGE 5 0.0003
693 ISCHAEMIC STROKE 6 0.0003
694 FACIAL PAIN 3 0.0003
695 THIRST 6 0.0003
696 COLON CANCER 5 0.0003
697 ROAD TRAFFIC ACCIDENT 14 0.0003
698 HAEMORRHAGE INTRACRANIAL 5 0.0003
699 MOBILITY DECREASED 24 0.0003
700 PNEUMONIA 108 0.0003
701 STAPHYLOCOCCAL INFECTION 11 0.0003
702 PALPITATIONS 39 0.0003
703 MOUTH ULCERATION 7 0.0003
704 OSTEOMYELITIS 6 0.0003
705 BLOOD PRESSURE DECREASED 22 0.0003
706 HERPES ZOSTER 19 0.0003
707 PRODUCT SUBSTITUTION ISSUE 19 0.0003
708 HYPOGLYCAEMIA 16 0.0003
709 SKIN DISORDER 11 0.0003
710 MYALGIA 56 0.0003
711 DEPRESSED LEVEL OF CONSCIOUSNESS 13 0.0003
712 SUICIDAL IDEATION 30 0.0003
713 JOINT INJURY 7 0.0003
714 INSURANCE ISSUE 5 0.0003
715 BRAIN NEOPLASM 3 0.0003
716 RESPIRATORY DISTRESS 9 0.0003
717 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
718 THYROID DISORDER 5 0.0003
719 LYMPHOMA 5 0.0003
720 CONJUNCTIVITIS 6 0.0003
721 OSTEONECROSIS OF JAW 8 0.0003
722 CYST 4 0.0003
723 DEMENTIA 9 0.0003
724 EXPOSURE DURING PREGNANCY 20 0.0003
725 PANCREATITIS 17 0.0003
726 DEPRESSED MOOD 17 0.0003
727 TOOTH EXTRACTION 4 0.0003
728 WHEEZING 19 0.0003
729 NERVOUS SYSTEM DISORDER 10 0.0003
730 INTESTINAL OBSTRUCTION 12 0.0003
731 BLOOD URINE PRESENT 6 0.0003
732 HAEMATEMESIS 8 0.0003
733 HALLUCINATION, AUDITORY 5 0.0003
734 ULCER 5 0.0003
735 HYPERKALAEMIA 11 0.0003
736 OEDEMA 17 0.0003
737 MALAISE 137 0.0003
738 BLOOD GLUCOSE DECREASED 15 0.0003
739 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 15 0.0003
740 THROAT IRRITATION 14 0.0003
741 GLAUCOMA 6 0.0003
742 MOVEMENT DISORDER 10 0.0003
743 ILLNESS 32 0.0003
744 ANOREXIA 4 0.0003
745 BLOOD POTASSIUM INCREASED 5 0.0003
746 RESPIRATORY TRACT INFECTION 8 0.0003
747 BLOOD CREATININE INCREASED 20 0.0003
748 ABDOMINAL PAIN 71 0.0003
749 DISABILITY 6 0.0003
750 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
751 RESPIRATORY DISORDER 9 0.0003
752 VIRAL INFECTION 10 0.0003
753 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7 0.0003
754 HAIR TEXTURE ABNORMAL 4 0.0003
755 MENTAL DISORDER 13 0.0003
756 LACRIMATION INCREASED 9 0.0003
757 EYE PRURITUS 10 0.0003
758 EMPHYSEMA 3 0.0003
759 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
760 PRURITUS 114 0.0003
761 SEPSIS 33 0.0003
762 PRODUCT TASTE ABNORMAL 4 0.0003
763 EYE IRRITATION 17 0.0003
764 DRY THROAT 3 0.0003
765 HYPERHIDROSIS 38 0.0003
766 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 53 0.0003
767 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
768 PRODUCT DOSE OMISSION 19 0.0003
769 APPLICATION SITE RASH 4 0.0003
770 ALOPECIA 57 0.0003
771 GASTROINTESTINAL DISORDER 26 0.0003
772 LOCAL SWELLING 5 0.0003
773 APHONIA 4 0.0003
774 RASH MACULAR 10 0.0003
775 HEART RATE DECREASED 10 0.0003
776 HYPONATRAEMIA 16 0.0003
777 BRONCHITIS 21 0.0003
778 INJECTION SITE PRURITUS 19 0.0003
779 INFECTION 41 0.0003
780 PAIN IN JAW 8 0.0003
781 PLASMA CELL MYELOMA 11 0.0003
782 HYPOTHYROIDISM 9 0.0003
783 SUBDURAL HAEMATOMA 4 0.0003
784 MULTIPLE SCLEROSIS RELAPSE 19 0.0003
785 ABDOMINAL PAIN LOWER 7 0.0003
786 MYELODYSPLASTIC SYNDROME 4 0.0003
787 INJECTION SITE HAEMATOMA 4 0.0003
788 DIABETES MELLITUS 21 0.0003
789 ARRHYTHMIA 13 0.0003
790 HEPATITIS 7 0.0003
791 UNRESPONSIVE TO STIMULI 7 0.0003
792 VISUAL ACUITY REDUCED 9 0.0003
793 BLOOD GLUCOSE INCREASED 51 0.0003
794 INJECTION SITE MASS 10 0.0003
795 DEVICE MALFUNCTION 19 0.0003
796 TACHYCARDIA 24 0.0003
797 MEDICATION ERROR 15 0.0003
798 GAIT INABILITY 9 0.0003
799 BACTERIAL INFECTION 5 0.0003
800 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
801 INJECTION SITE ERYTHEMA 33 0.0003
802 GASTRITIS 7 0.0003
803 PREMATURE BABY 8 0.0003
804 PRODUCT QUALITY ISSUE 36 0.0003
805 UNEVALUABLE EVENT 20 0.0003
806 ECONOMIC PROBLEM 4 0.0003
807 ERYTHEMA 54 0.0003
808 MUSCULOSKELETAL STIFFNESS 23 0.0003
809 DISEASE PROGRESSION 31 0.0003
810 DRUG PRESCRIBING ERROR 5 0.0003
811 PAIN OF SKIN 7 0.0003
812 AGGRESSION 13 0.0003
813 PERICARDIAL EFFUSION 6 0.0003
814 NEOPLASM PROGRESSION 9 0.0003
815 TENDONITIS 4 0.0003
816 FEMUR FRACTURE 8 0.0003
817 CAESAREAN SECTION 3 0.0003
818 MOOD ALTERED 7 0.0003
819 OCULAR HYPERAEMIA 12 0.0003
820 PNEUMOTHORAX 4 0.0003
821 SEIZURE 29 0.0003
822 ABSCESS 4 0.0003
823 HAEMORRHAGE 26 0.0002
824 HEPATITIS C 3 0.0002
825 PRODUCT PHYSICAL ISSUE 5 0.0002
826 EMOTIONAL DISTRESS 30 0.0002
827 EXTRA DOSE ADMINISTERED 10 0.0002
828 DRUG INTERACTION 39 0.0002
829 THERAPY NON-RESPONDER 11 0.0002
830 ENCEPHALOPATHY 6 0.0002
831 ANGINA PECTORIS 7 0.0002
832 CHEST DISCOMFORT 25 0.0002
833 RASH 106 0.0002
834 MANIA 4 0.0002
835 HYPERCALCAEMIA 3 0.0002
836 PYREXIA 84 0.0002
837 DRUG DEPENDENCE 39 0.0002
838 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
839 THROMBOCYTOPENIA 27 0.0002
840 TOOTH LOSS 5 0.0002
841 ASTHMA 27 0.0002
842 ASCITES 7 0.0002
843 RENAL IMPAIRMENT 20 0.0002
844 INJECTION SITE HAEMORRHAGE 19 0.0002
845 THERAPY INTERRUPTED 17 0.0002
846 CIRCULATORY COLLAPSE 4 0.0002
847 SCAR 4 0.0002
848 GASTRIC DISORDER 8 0.0002
849 URTICARIA 39 0.0002
850 PRODUCT DOSE OMISSION ISSUE 68 0.0002
851 CONDITION AGGRAVATED 70 0.0002
852 MULTIPLE SCLEROSIS 11 0.0002
853 PRODUCT PRESCRIBING ISSUE 5 0.0002
854 DISCOMFORT 14 0.0002
855 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
856 DRUG ABUSE 19 0.0002
857 ANKYLOSING SPONDYLITIS 3 0.0002
858 COLD SWEAT 4 0.0002
859 LYMPHOCYTE COUNT DECREASED 4 0.0002
860 BRADYCARDIA 12 0.0002
861 ADVERSE REACTION 3 0.0002
862 DRUG ERUPTION 4 0.0002
863 INJECTION SITE BRUISING 18 0.0002
864 EYE HAEMORRHAGE 3 0.0002
865 LUNG DISORDER 11 0.0002
866 SWELLING 21 0.0002
867 THROMBOSIS 18 0.0002
868 MYOCARDIAL INFARCTION 39 0.0002
869 DRUG EFFECT DECREASED 12 0.0002
870 SYNOVITIS 4 0.0002
871 OFF LABEL USE 194 0.0002
872 CHROMATURIA 5 0.0002
873 BLINDNESS 9 0.0002
874 PALLOR 6 0.0002
875 APPLICATION SITE PRURITUS 5 0.0002
876 DRUG TOXICITY 3 0.0002
877 WRONG TECHNIQUE IN DRUG USAGE PROCESS 8 0.0002
878 RESPIRATORY ARREST 6 0.0002
879 DRY SKIN 29 0.0002
880 ANAPHYLACTIC REACTION 12 0.0002
881 COMPLETED SUICIDE 18 0.0002
882 RHABDOMYOLYSIS 9 0.0002
883 CARDIO-RESPIRATORY ARREST 9 0.0002
884 BLOOD TEST ABNORMAL 3 0.0002
885 SKIN EXFOLIATION 18 0.0002
886 DEVICE OCCLUSION 3 0.0002
887 INFUSION RELATED REACTION 14 0.0002
888 IMPAIRED QUALITY OF LIFE 3 0.0002
889 TYPE 2 DIABETES MELLITUS 7 0.0002
890 HERNIA 4 0.0002
891 PRESCRIBED OVERDOSE 4 0.0002
892 ADVERSE EVENT 19 0.0002
893 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
894 CHOKING 4 0.0002
895 ORAL HERPES 4 0.0002
896 ACUTE MYOCARDIAL INFARCTION 6 0.0002
897 URINARY INCONTINENCE 6 0.0002
898 DELIRIUM 7 0.0002
899 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
900 NEUTROPENIA 27 0.0002
901 PANCYTOPENIA 11 0.0002
902 INJECTION SITE RASH 6 0.0002
903 NEOPLASM MALIGNANT 13 0.0002
904 ERECTILE DYSFUNCTION 5 0.0002
905 LUNG NEOPLASM MALIGNANT 8 0.0002
906 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
907 INJECTION SITE WARMTH 4 0.0002
908 HYPERSENSITIVITY 36 0.0002
909 CARDIAC ARREST 16 0.0002
910 COVID-19 34 0.0002
911 EXPOSURE VIA SKIN CONTACT 5 0.0002
912 CARDIAC DISORDER 18 0.0002
913 HYPERGLYCAEMIA 7 0.0002
914 BONE DENSITY DECREASED 6 0.0002
915 KNEE ARTHROPLASTY 4 0.0002
916 DISEASE RECURRENCE 9 0.0002
917 IMPAIRED WORK ABILITY 4 0.0002
918 MENSTRUATION IRREGULAR 5 0.0002
919 INJECTION SITE PAIN 57 0.0002
920 DISTURBANCE IN ATTENTION 10 0.0002
921 FREQUENT BOWEL MOVEMENTS 5 0.0002
922 THROAT TIGHTNESS 5 0.0002
923 DRUG INEFFECTIVE 240 0.0002
924 MELAENA 4 0.0002
925 LIP SWELLING 6 0.0002
926 LEUKOPENIA 9 0.0002
927 RASH MACULO-PAPULAR 4 0.0002
928 CELLULITIS 9 0.0002
929 PANCREATITIS ACUTE 4 0.0002
930 DRUG EXPOSURE DURING PREGNANCY 6 0.0002
931 PSORIASIS 23 0.0002
932 NEUTROPHIL COUNT DECREASED 7 0.0002
933 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
934 PSYCHOTIC DISORDER 5 0.0002
935 SYSTEMIC LUPUS ERYTHEMATOSUS 6 0.0002
936 PRODUCT PRESCRIBING ERROR 4 0.0002
937 FEBRILE NEUTROPENIA 11 0.0002
938 ILL-DEFINED DISORDER 10 0.0002
939 TREATMENT NONCOMPLIANCE 9 0.0002
940 UNDERDOSE 12 0.0002
941 INJECTION SITE URTICARIA 4 0.0002
942 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 33 0.0002
943 BLOOD GLUCOSE ABNORMAL 3 0.0002
944 DRUG WITHDRAWAL SYNDROME 14 0.0002
945 FRACTURE 3 0.0002
946 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
947 GENERAL PHYSICAL HEALTH DETERIORATION 18 0.0002
948 APPLICATION SITE ERYTHEMA 4 0.0002
949 RHEUMATOID ARTHRITIS 17 0.0001
950 CARDIAC FAILURE 12 0.0001
951 DEVICE BREAKAGE 6 0.0001
952 DEVICE ISSUE 13 0.0001
953 INJECTION SITE SWELLING 11 0.0001
954 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
955 NEEDLE ISSUE 4 0.0001
956 HOSPITALISATION 21 0.0001
957 DEATH 117 0.0001
958 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
959 DRUG INTOLERANCE 13 0.0001
960 HEPATIC FUNCTION ABNORMAL 5 0.0001
961 ACNE 10 0.0001
962 INJECTION SITE REACTION 9 0.0001
963 EMOTIONAL DISORDER 4 0.0001
964 MALIGNANT NEOPLASM PROGRESSION 13 0.0001
965 LACTIC ACIDOSIS 4 0.0001
966 PSORIATIC ARTHROPATHY 5 0.0001
967 OSTEONECROSIS 4 0.0001
968 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
969 CARDIOVASCULAR DISORDER 3 0.0001
970 THERAPEUTIC RESPONSE DECREASED 7 0.0001
971 VAGINAL HAEMORRHAGE 5 0.0001
972 DEVICE DISLOCATION 5 0.0001
973 ANGIOEDEMA 5 0.0001
974 COLITIS ULCERATIVE 5 0.0001
975 PRODUCT STORAGE ERROR 9 0.0001
976 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
977 MATERNAL EXPOSURE DURING PREGNANCY 9 0.0001
978 ADVERSE DRUG REACTION 9 0.0001
979 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7 0.0001
980 EPILEPSY 3 0.0001
981 SKIN BURNING SENSATION 7 0.0001
982 DRUG-INDUCED LIVER INJURY 3 0.0001
983 SEPTIC SHOCK 4 0.0001
984 DEPENDENCE 5 0.0001
985 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
986 SKIN IRRITATION 4 0.0001
987 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 4 0.0001
988 INCORRECT ROUTE OF DRUG ADMINISTRATION 3 0.0001
989 INFLAMMATION 4 0.0001
990 NO ADVERSE EVENT 14 0.0001
991 ECZEMA 4 0.0001
992 DERMATITIS ATOPIC 4 0.0001
993 DEVICE LEAKAGE 3 0.0001
994 BREAST CANCER 4 0.0000